Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Mild to Moderate Ankle Sprain

NCT00927641 is registered in ClinicalTrials.gov with Hisamitsu Pharmaceutical Co., Inc. as lead sponsor.

NCT NCT00927641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00927641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Mild to Moderate Ankle Sprain
Lead sponsor
Hisamitsu Pharmaceutical Co., Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2009
Completion date
November 30, 2010
Enrollment
240 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

ankle sprain